Our blood-based tissue-derived biomarkers can quantify changes in joint tissues (e.g. bone, cartilage and connective tissues), and they can be used for monitoring pharmacodynamics, prognosis and prediction of efficacy in Rheumatoid Arthritis.
 

More about our biomarkers for Rheumatoid Arthritis

Find publications

Our blood-based tissue-derived biomarkers can quantify changes occurring in patients with SpA by reflecting the diagnostic status of the three key affected tissues; ankylosis (bone), fibrosis (connective tissue) and chronic inflammation, and thereby be one step closer to personalized medicine.

 

More about our biomarkers for Spondyloarthritis

Find publications

Our non-invasive blood biomarkers have a lot of value to add for studies in osteoarthritis, and for safety studies where structural changes to the joint are necessary to monitor. Read more about how disease activity can be monitored with the aid of Nordic Bioscience biomarkers, or understand to a deeper extent how the pharmacodynamic modulation occurs. 

More about our biomarkers for Osteoarthritis

Find publications

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.

We use cookies on our site to enable essential services and functionalities, and collect data in regards to visitor information. This is done in order to provide the best possible experience for the visitor. Cookie policy Privacy statement